Drug Type Synthetic peptide |
Synonyms Atrial natriuretic factor (95-126), Atrial natriuretic factor prohormone (95-126), Ularitide acetate + [10] |
Target |
Mechanism NPR agonists(Atrial natriuretic peptide receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute decompensated heart failure | Phase 3 | US | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | AR | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | BE | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | BR | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | CA | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | CZ | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | EE | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | FI | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | FR | 01 Jul 2012 | |
Acute decompensated heart failure | Phase 3 | DE | 01 Jul 2012 |
Phase 3 | 2,157 | hyruhulidd(pqxbljnsxd) = dttkizbtgz akamgwlpyi (hgejkjjwzg ) | Positive | 18 May 2017 | |||
Placebo | hyruhulidd(pqxbljnsxd) = hwgjckxvci akamgwlpyi (hgejkjjwzg ) |